Tower Research Capital LLC (TRC) - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 31 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,210
+116.2%
6,753
+160.5%
0.00%
Q2 2023$5,184
+172700.0%
2,592
+61.8%
0.00%
Q1 2023$3
-100.0%
1,602
-75.2%
0.00%
Q1 2022$7,0006,465
+8879.2%
0.00%
Q4 2021$0
-100.0%
72
-98.5%
0.00%
Q2 2021$9,000
+80.0%
4,658
+328.1%
0.00%
Q1 2021$5,0001,0880.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders